Clinical Trials Directory

Trials / Completed

CompletedNCT00756808

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?

Is Tuberculin Skin Testing Effective in Screening for Latent TB in Elderly Residents of Nursing Homes? Comparison With a New IFN-y Based Assay

Status
Completed
Phase
Study type
Observational
Enrollment
135 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

In face of the increased rates of tuberculosis in residents of long term care facilities, annual screening for latent tuberculosis is recommended. Tuberculin skin testing using purified protein derivative (PPD) is used for this purpose. Sensitivity of the PPD testing is, however, dependent on a normal T cell function. It is now evident that the immune system undergoes age-associated alteration known as immune senescence. The depressed T-cell responses may clinically manifest as attenuated delayed-type hypersensitivity. This attenuated reaction may affect the sensitivity of the PPD in detection of latent TB in the elderly. This prospective study will examine the utility of interferon-gamma (IFN-γ) based assay, T-SPOT.TB, for detection of latent tuberculosis in nursing home patients who are 65 years of age or older.

Conditions

Timeline

Start date
2007-10-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2008-09-22
Last updated
2014-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00756808. Inclusion in this directory is not an endorsement.